Generalized Anxiety Disorder
Conditions
Interventions
High-dose group:N/A
Placebo control group:N/A
Low-dose group:N/A
Sponsors
Beijing Anding Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Subjects who have signed the main study informed consent and successfully passed screening for enrollment; 2.Be capable of fully understanding and signing the informed consent form for this extended observational study; 3.Subjects shall have no contraindications to venous blood collection, exhibit normal coagulation function, and be able to cooperate with the additional blood collection procedures scheduled at each visit.
Exclusion criteria
Exclusion criteria: 1.Subjects who have seriously violated the protocols of both the main trial and this observational study; 2.Subjects with severe anemia or coagulation disorders; 3.Other conditions judged by the investigator to render the subject ineligible for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma levels of Corticotropin-Releasing Factor;Adrenocorticotropic Hormone;Omics-related indicators;Cortisol levels; | — |
Countries
China
Contacts
Public ContactGang Wang
Beijing An Ding Hospital, Capital Medical University
Outcome results
None listed